Search Results

This CBHSQ Spotlight presents findings from an evaluation of the State Pilot Program for Treatment for Pregnant and Postpartum Women (PPW-PLT). This pilot program was designed to complement the residential PPW program by developing a continuum of family-centered care services in an outpatient setting. This spotlight compares program clients’ self-reported...

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...

Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...

Read key findings from the 2020 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Unlike other NSDUH Annual National Reports, the 2020 report has no comparisons...

Use this summary report to properly interpret 2020 NSDUH estimates of substance use and mental health issues. The report accompanies the annual detailed tables and covers overall methodology, key definitions for measures and terms used in 2020 NSDUH reports and tables, and selected analyses of the measures and how they...

These state profiles include data from facilities that reported to N-SSATS for the survey reference date March 29, 2019. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...

These state profiles includes data from facilities that reported to N-SSATS for the survey reference date March 30, 2018. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

This state profile includes data from facilities in the United that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in the...

This report presents results from the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and...

These detailed tables are population illicit drug use totals and prevalence estimates from the 2010 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...

This state profile includes data from facilities in North Carolina that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in North...

This state profile includes data from facilities in North Dakota that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in North...